Compare VRCA & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRCA | PVL |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 57.8M |
| IPO Year | 2018 | N/A |
| Metric | VRCA | PVL |
|---|---|---|
| Price | $5.11 | $1.70 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 130.4K | 86.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $372.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $1.30 |
| 52 Week High | $9.82 | $2.04 |
| Indicator | VRCA | PVL |
|---|---|---|
| Relative Strength Index (RSI) | 30.58 | 41.81 |
| Support Level | $3.96 | $1.40 |
| Resistance Level | $5.23 | $1.88 |
| Average True Range (ATR) | 0.42 | 0.05 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 8.66 | 37.50 |
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.